AFYREN SA
PAR:ALAFY
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.43
3.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AFYREN SA
AFYREN SA
Income from Continuing Operations
AFYREN SA
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AFYREN SA
PAR:ALAFY
|
Income from Continuing Operations
-€9.6m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Global Bioenergies SA
PAR:ALGBE
|
Income from Continuing Operations
-€7.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-2%
|
|
|
Soc D Explosifs Produits Chimiques SA
PAR:EXPL
|
Income from Continuing Operations
€23.1m
|
CAGR 3-Years
56%
|
CAGR 5-Years
28%
|
CAGR 10-Years
25%
|
|
AFYREN SA
Glance View
Afyren SAS engages in the development of microbiology and bioprocess engineering from non-food biomass. The company is headquartered in Clermont-Ferrand, Auvergne-Rhone-Alpes and currently employs 70 full-time employees. The company went IPO on 2021-10-01. The firm focuses on the microbiology and bioprocess engineering that develops industrial process, named AFYNERIE, to convert non-food biomass to bioenergy. The company provides measurement of the factory's methanogenic potential and laboratory analysis of waste, among others. The company also allows to grow from a pilot stage to industrial-scale production that offers a wide panel of industries, bio sourced replacements with an environmentally friendly technology that uses natural microorganisms. AFYREN’s corporate culture works based on three core values that have driven the progress and laid the foundation for future achievements: commitment, agility and humility.
See Also
What is AFYREN SA's Income from Continuing Operations?
Income from Continuing Operations
-9.6m
EUR
Based on the financial report for Dec 31, 2023, AFYREN SA's Income from Continuing Operations amounts to -9.6m EUR.
What is AFYREN SA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-65%
Over the last year, the Income from Continuing Operations growth was -4%. The average annual Income from Continuing Operations growth rates for AFYREN SA have been -65% over the past three years .
You don't have any saved screeners yet
